TrialThe New England journal of medicine2020

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children.

Véronique Minard-Colin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.